Physiology:
Summary |
· Preload-dependent · Slow response to pain · Slow response to blood loss · Absence of angina |
Autonomic systems |
· PSNS: absent · Neural SNS: absent · Humoral SNS: present |
Heart rate |
· Resting: ↑ (90-100) · Max: ↓ · Variability: ↓ |
Slow response to |
· Pain · Hypovolaemia, hypotension · Exercise |
Absent responses to |
· Carotid sinus massage · Valsalva |
Atrial dysfunction |
· Asynchrony · Filling impairment · AF and AFL in 25% |
Preserved autoregulation |
· Coronary autoregulation · Heterometric autoregulation (Frank-Starling) |
Pharmacology:
↑Response to catecholamines |
· Adrenaline · Noradrenaline · Dobutamine · Isoprenaline |
↓Response to indirect acting pressors |
· Ephedrine · Metaraminol |
↔Response to direct acting pressors (why not increased??) |
· Phenylephrine |
↓Response to anti-muscarinics |
· Atropine · Glycopyrrolate |
Beware negative chronotropes |
· Beta blockers · Calcium channel blockers · Neostigmine |
Assessment:
Goals |
· Function of transplant? · Severity of comorbidities? · Severity of present illness? · Urgency of surgery? |
History/Exam/Tests |
· Function of transplant o Details regarding surgery o History of rejection o Exercise capacity (DASI) o Recent echo · Severity of comorbidities o Accelerated coronary artery disease o Arrhythmia o HTN o T2DM o CKD o CLD (liver) o Cytopaenias o Cancer · Severity of present illness o End-organ dysfunction o Volume status · Urgency of surgery o Discussion with surgeon |
Specific tests |
· Blood tests: o FBE, UEC, LFT, coag, lactate · ECG: o Signs of Tx: double P wave, 1st degree AV block, RBBB o Signs of IHD · PPM/AICD interrogation o PPM dependence o Response to magnet |
Optimisation |
· Medications plan: o Immunosuppressants o Anticoagulants o Antihypertensives · Fluid resuscitation o Preload-dependent |
Planning |
· Discussion o Transplant centre o Local cardiology o Local ICU · Decision: o If urgent and low risk: proceed o If non-urgent and high risk: transfer o If in between: depends on discussion and goals |
Anaesthesia:
Goals |
· No cardiovascular collapse · No myocardial ischaemia · No infection (wound, lines) |
Preparation |
· Access: o Strict asepsis o Avoid IJ CVC (facilitate future biopsies) · Personnel: o Second anaesthetist if complex · Monitoring o 5 lead ECG o Low threshold for arterial line · Drugs: o Metaraminol for infusion (0.5mg/mL) o Adrenaline for boluses (10mcg/mL) o Adrenaline or isoprenaline for infusion |
Induction |
· IV fluid bolus 10mL/kg · Midazolam 0.025mg/kg · Fentanyl 5mcg/kg · Propofol 2mg/kg · Metaraminol infusion at 5mg/h · Low threshold for small adrenaline boluses · Antibiotic 30-60 mins pre-incision |
Maintenance |
· |
Emergence |
· No myocardial ischaemia o Deep extubation if safe o Plenty of opioid if extubating awake |
Post-op |
· Consider ICU/HDU monitoring |
Indications:
Clinical |
· NYHA 3,4 heart failure (dilated > ischaemic > congenital > other) · Refractory arrhythmia · Refractory angina |
Testing |
· VO2peak <12mL/kg/min · Severe LV systolic dysfunction |
Scores |
· Heart failure survival score medium-high risk · Seattle heart failure survival model at 1 year <80% |
Goldilocks timing |
· Too early: pointless and wasteful · Too late: dangerous |
Contra-indications:
Absolute |
· Severe kidney disease (CrCl <40) · Severe liver disease (BR >50) · Severe lung disease (FEV1 < 1L) · Severe pulmonary vascular disease (PASP >60mmHg or PVR >4) · Severe psychological problems (expect non-compliance) |
Relative |
· Uncontrolled diabetes (HbA1c >7.5%) · Obesity · Substance abuse · Cancer · Blood-borne virus · Systemic infection |
Ideal donor:
Demographics |
· Young · Sex match · Race match · Body size match |
Health |
· Normal heart · Normal pulmonary vasculature · Normal lungs · Normal kidneys · No substance abuse · No infection · (And total ischaemic time <4 hours) |
Ventricular assist devices:
Benefits |
· Allow exercise · Allow weight gain · Improved organ function (esp kidneys) *Almost half of transplant recipients were bridged with a VAD* |
Risks |
· Infection · Thrombosis · Malfunction · RV failure |
Peri-op consideration |
· Record the settings · ↑Risk of bleeding because: o Re-sternotomy o Acquired coagulopathy (incl vWF deficiency) |
Investigations:
CPET |
· VO2peak (<12 gets transplant, note underestimated in the obese) · VEVCO2 (strongest predictor) |
RHC |
· Direct: CO, SvO2, RAP, RVP, mPAP, PASP, PADP, PCWP · Indirect: PVR, TPG, DPG *If severe PHTN, then donor RV won’t cope* |
Anaesthesia:
Goals |
· No arrest at induction · No awareness · No bleeding to death · No clotting to death (bypass) |
Pre-induction |
Medication: · Reverse anticoagulation (Vit K, PCC, FFP) · Continue pulmonary vasodilators · Continue inotropes · Immunosuppression (glucocorticoid, azathioprine etc) – d/w home team · Antibiotic prophylaxis
Fluid: · Crystalloid resuscitation · Blood crossmatch
Access: · Big peripheral IV · Arterial line · CVC with PAC
Monitoring: · TOE · NIRS · BIS
Pacing: · Reprogramme AICD/PPM: o Deactivate shock and anti-tachy o Activate DOO · Apply external defib pads
VAD: · Note settings |
Induction |
Goals: · Maintain heart rate · Maintain contractility · Maintain afterload · Maintain preload · Maintain normal O2 and CO2 Drugs: · Midazolam 1-5mg · Fentanyl 2-4mcg/kg · Propofol 0-1mg/kg · Rocuronium (fast onset) · (can substitute etomidate for propofol) |
Going on bypass |
· Withdraw PAC · Clamp VAD outflow graft (surgeons) |
Coming off bypass |
· LV and RV function · Anastomosis sites · Air in LV apex · Flow through pulmonary veins |
Post-op |
Homeostasis: · Oxygenation · Ventilation · Blood volume · Heart rate (80-100) · mAP · mPAP and PVR (Rx milrinone, iNO, PDE5i, PGI2) · Temperature · Acid-base Watch out for: · Signs of tamponade · Signs of RV failure · Arrhythmia Other complications: · Primary graft dysfunction · Secondary graft dysfunction · Cardiac allograft vasculopathy · Drug nephrotoxicity |
Feedback welcome at ketaminenightmares@gmail.com